[Author Disclosure: This content reflects the views of the author and is provided for informational purposes only. It does not constitute investment advice and is not a recommendation or endorsement by BioTech Funding Portal. Any investment decision should be based solely on the issuer’s official offering materials.]
We’ve published a comprehensive set of investor education materials to help participants better understand how Regulation Crowdfunding works on the BioTech Funding Portal. These resources are intended to explain the mechanics of crowdfunding offerings, the role of a registered funding portal, and the regulatory framework governing issuers and investors. Whether you are new to crowdfunding or reviewing an offering, these materials are designed to provide foundational information before you consider participating in any investment opportunity.
The Education Center covers key topics such as issuer eligibility, required disclosures through Form C, investment limits, investor cancellation rights, communication channels, and transaction confirmations. It also explains common security types that may be offered on the platform, including SAFEs, and outlines how these instruments generally function. In addition, the materials describe the funding portal’s limited role under federal securities laws and clarify that BioTech Funding Portal LLC does not provide investment advice, recommendations, or suitability determinations.
Crowdfunding investments involve significant risks, including limited liquidity, resale restrictions, dilution, valuation uncertainty, and the potential loss of an investor’s entire investment. The Education Center summarizes these risks and highlights the importance of conducting independent due diligence and reviewing all issuer-provided disclosures before investing. We encourage community members to review the full education materials carefully and consult with qualified financial, tax, or legal professionals as appropriate.
- BioTech Funding Portal Support
Register for FREE to comment or continue reading this article. Already registered? Login here.
1